Your browser doesn't support javascript.
loading
Identifying transcriptional programs underlying cancer drug response with TraCe-seq.
Chang, Matthew T; Shanahan, Frances; Nguyen, Thi Thu Thao; Staben, Steven T; Gazzard, Lewis; Yamazoe, Sayumi; Wertz, Ingrid E; Piskol, Robert; Yang, Yeqing Angela; Modrusan, Zora; Haley, Benjamin; Evangelista, Marie; Malek, Shiva; Foster, Scott A; Ye, Xin.
  • Chang MT; Department of Computational Biology and Bioinformatics, Genentech Inc., South San Francisco, CA, USA.
  • Shanahan F; Department of Discovery Oncology, Genentech Inc., South San Francisco, CA, USA.
  • Nguyen TTT; Department of Discovery Oncology, Genentech Inc., South San Francisco, CA, USA.
  • Staben ST; Department of Computational Biology and Bioinformatics, Genentech Inc., South San Francisco, CA, USA.
  • Gazzard L; Department of Discovery Chemistry, Genentech Inc., South San Francisco, CA, USA.
  • Yamazoe S; Department of Discovery Chemistry, Genentech Inc., South San Francisco, CA, USA.
  • Wertz IE; Department of Discovery Chemistry, Genentech Inc., South San Francisco, CA, USA.
  • Piskol R; Discovery Biotherapeutics, Bristol-Myers Squibb, Redwood City, CA, USA.
  • Yang YA; Department of Discovery Oncology, Genentech Inc., South San Francisco, CA, USA.
  • Modrusan Z; Department of Early Discovery Biochemistry, Genentech Inc., South San Francisco, CA, USA.
  • Haley B; Department of Computational Biology and Bioinformatics, Genentech Inc., South San Francisco, CA, USA.
  • Evangelista M; Department of Microchemistry, Proteomics and Lipidomics, Genentech Inc., South San Francisco, CA, USA.
  • Malek S; Department of Microchemistry, Proteomics and Lipidomics, Genentech Inc., South San Francisco, CA, USA.
  • Foster SA; Department of Molecular Biology, Genentech Inc., South San Francisco, CA, USA.
  • Ye X; Department of Discovery Oncology, Genentech Inc., South San Francisco, CA, USA.
Nat Biotechnol ; 40(1): 86-93, 2022 01.
Article en En | MEDLINE | ID: mdl-34531539

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article